Safety and Efficacy of Duloxetine Versus Venlafaxine in Major Depression in Indian Patients

Simple item page
dc.contributor.authorBadyal, Dinesh K
dc.contributor.authorKhosla, Prem P
dc.contributor.authorDeswal, Rajinder S
dc.contributor.authorMatreja, Prithpal S
dc.date.accessioned2016-02-01T06:26:23Z
dc.date.available2016-02-01T06:26:23Z
dc.date.issued2006-10
dc.description.abstractThe objective of the study was to compare the efficacy and safety of duloxetine and venlafaxine in major depressive disorder. The study was conducted in 26 patients suffering from major depressive disorder as per DSM-IV criteria. Patients were randomized to two groups and were given duloxetine (20,40,60mg BD) and venlafaxine (75,150,225mg OD) for 6 weeks. The primary efficacy parameter was the Hamilton Depression Rating Scale (HDRS-17). Secondary efficacy parameters included the Montgomery and Asberg depression rating scale (MADRS) and clinical global impression (CGI) scale. Safety evaluation was based on treatment emergent adverse effects and laboratory investigations. There was significant decrease in HDRS, MADRS, CGI scores from baseline to endpoint (p<0.05) in both the groups. However the difference in scores between two groups was not statistically significant. Total mean HDRS score decreased from 27(SD=2.5) to 4 (SD=1.2) in duloxetine group and from 29(SD=2.3) to 4 (SD=1.0) in venlafaxine group at the end of therapy. Response and remission rate was 96% and 69% in duloxetine group as compared to 92% and 62% in venlafaxine group respectively. There was no significant difference in adverse effects and laboratory investigation in two groups. The findings of this study indicate that duloxetine may be an effective and safe antidepressant in Indian patients of major depressive disorder. It is equally effective to venlafaxine in patients of depression.en_US
dc.identifier.citationBadyal Dinesh k, Khosla Prem P, Deswal Rajinder S, Materja Prithpal S. Safety and Efficacy of Duloxetine Versus Venlafaxine in Major Depression in Indian Patients. JK Science Journal of Medical Education and Research. 2006 Oct-Dec;8(4): 195-199en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/171343
dc.language.isoenen_US
dc.source.urihttps://www.jkscience.org/archive/vol8a/safety.pdfen_US
dc.subjectDuloxetineen_US
dc.subjectVenlafaxineen_US
dc.subjectDepressionen_US
dc.titleSafety and Efficacy of Duloxetine Versus Venlafaxine in Major Depression in Indian Patientsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
jksjmer2006v8n4p195.pdf
Size:
117.3 KB
Format:
Adobe Portable Document Format
Description:
Original Articles
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
JK Science Journal of Medical Education and Research